Literature DB >> 16183655

Ribonucleoprotein particle formation is necessary but not sufficient for LINE-1 retrotransposition.

Deanna A Kulpa1, John V Moran.   

Abstract

Long interspersed elements (LINE-1s or L1s) are abundant non-LTR retrotransposons that mobilize through an RNA intermediate by target site primed reverse transcription. The L1-encoded proteins (ORF1p and ORF2p) preferentially associate with their encoding transcript to form a ribonucleoprotein particle (RNP), which is a proposed retrotransposition intermediate. Here, we have used epitope tagging to discriminate the proteins encoded by engineered L1s from those encoded by endogenously expressed L1s. We demonstrate that an L1 containing an epitope tag at the carboxyl terminus of ORF1p remains retrotransposition-competent and that tagged ORF1p and its encoding RNA localize to cytoplasmic RNPs. We also identified two classes of ORF1p mutants, one that severely decreased RNP formation and blocked retrotransposition, and another that allows RNP formation but reduces retrotransposition by 100-fold. Thus, these data indicate that RNP formation is important but not sufficient for L1 retrotransposition and suggest that ORF1p also may function at downstream steps in the L1 retrotransposition pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183655     DOI: 10.1093/hmg/ddi354

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  106 in total

Review 1.  Active human retrotransposons: variation and disease.

Authors:  Dustin C Hancks; Haig H Kazazian
Journal:  Curr Opin Genet Dev       Date:  2012-03-08       Impact factor: 5.578

2.  Self-interaction, nucleic acid binding, and nucleic acid chaperone activities are unexpectedly retained in the unique ORF1p of zebrafish LINE.

Authors:  Mitsuhiro Nakamura; Norihiro Okada; Masaki Kajikawa
Journal:  Mol Cell Biol       Date:  2011-11-21       Impact factor: 4.272

3.  Similarities between long interspersed element-1 (LINE-1) reverse transcriptase and telomerase.

Authors:  Huira C Kopera; John B Moldovan; Tammy A Morrish; Jose Luis Garcia-Perez; John V Moran
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-22       Impact factor: 11.205

4.  Reprogramming somatic cells into iPS cells activates LINE-1 retroelement mobility.

Authors:  Silke Wissing; Martin Muñoz-Lopez; Angela Macia; Zhiyuan Yang; Mauricio Montano; William Collins; Jose Luis Garcia-Perez; John V Moran; Warner C Greene
Journal:  Hum Mol Genet       Date:  2011-10-11       Impact factor: 6.150

5.  Epigenetic control of retrotransposon expression in human embryonic stem cells.

Authors:  Angela Macia; Martin Muñoz-Lopez; Jose Luis Cortes; Robert K Hastings; Santiago Morell; Gema Lucena-Aguilar; Juan Antonio Marchal; Richard M Badge; Jose Luis Garcia-Perez
Journal:  Mol Cell Biol       Date:  2010-11-01       Impact factor: 4.272

6.  LINE-1 activity as molecular basis for genomic instability associated with light exposure at night.

Authors:  Victoria P Belancio
Journal:  Mob Genet Elements       Date:  2015-04-07

7.  Phosphorylation of ORF1p is required for L1 retrotransposition.

Authors:  Pamela R Cook; Charles E Jones; Anthony V Furano
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

8.  Essential domains for ribonucleoprotein complex formation required for retrotransposition of telomere-specific non-long terminal repeat retrotransposon SART1.

Authors:  Takumi Matsumoto; Mitsuhiro Hamada; Mizuko Osanai; Haruhiko Fujiwara
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

9.  LINE-like retrotransposition in Saccharomyces cerevisiae.

Authors:  Chun Dong; Russell T Poulter; Jeffrey S Han
Journal:  Genetics       Date:  2008-10-28       Impact factor: 4.562

10.  Efficient translation initiation directed by the 900-nucleotide-long and GC-rich 5' untranslated region of the human retrotransposon LINE-1 mRNA is strictly cap dependent rather than internal ribosome entry site mediated.

Authors:  Sergey E Dmitriev; Dmitri E Andreev; Ilya M Terenin; Ivan A Olovnikov; Vladimir S Prassolov; William C Merrick; Ivan N Shatsky
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.